Parkinson’s disease is a progressive neurodegenerative disease often accompanied by significant psychological complications, in particular, by occurrence of suicidal ideation. It usually arises from a complex interplay of biological, psychological, and social factors including disease progression, non motor symptoms such as depression and anxiety, functional decline and treatment-related effects. This narrative review explores the current scientific understanding of suicide ideation in Parkinson’s, examining demographic, clinical and treatment-related factors which could help identify individuals at high risk of progression from suicide ideation to suicidal behaviour while highlighting the key research gaps and limitations. The literature search was conducted using databases PubMed, PsycInfo, Google Scholar, Medline and Scopus. Suicidality in Parkinson’s patients was delineated as an urgent issue in existing studies that has to be addressed on a spectrum, ranging from passive ideation to active planning and attempts. Many patients with suicide ideation but without active behaviours remain undetected and treatment is provided only after reaching a crisis point. Despite growing awareness, issues such as inconsistent definitions of suicide ideation, lack of longitudinal studies and underreporting limit the ability to draw firm scientific conclusions. This review underscores the clinical importance of early mental health screening and support for the patients.

Suicide ideation in Parkinson's disease

BABUSHKINA, NATALIIA
2024/2025

Abstract

Parkinson’s disease is a progressive neurodegenerative disease often accompanied by significant psychological complications, in particular, by occurrence of suicidal ideation. It usually arises from a complex interplay of biological, psychological, and social factors including disease progression, non motor symptoms such as depression and anxiety, functional decline and treatment-related effects. This narrative review explores the current scientific understanding of suicide ideation in Parkinson’s, examining demographic, clinical and treatment-related factors which could help identify individuals at high risk of progression from suicide ideation to suicidal behaviour while highlighting the key research gaps and limitations. The literature search was conducted using databases PubMed, PsycInfo, Google Scholar, Medline and Scopus. Suicidality in Parkinson’s patients was delineated as an urgent issue in existing studies that has to be addressed on a spectrum, ranging from passive ideation to active planning and attempts. Many patients with suicide ideation but without active behaviours remain undetected and treatment is provided only after reaching a crisis point. Despite growing awareness, issues such as inconsistent definitions of suicide ideation, lack of longitudinal studies and underreporting limit the ability to draw firm scientific conclusions. This review underscores the clinical importance of early mental health screening and support for the patients.
2024
Suicide ideation in Parkinson's disease
Parkinson's disease
Suicide ideation
Non-motor symptoms
Psychiatric symptoms
Suicide risk
File in questo prodotto:
File Dimensione Formato  
Babushkina_Nataliia.pdf

Accesso riservato

Dimensione 934.26 kB
Formato Adobe PDF
934.26 kB Adobe PDF

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/96509